These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 7540654)

  • 1. T cell priming versus T cell tolerance induced by synthetic peptides.
    Aichele P; Brduscha-Riem K; Zinkernagel RM; Hengartner H; Pircher H
    J Exp Med; 1995 Jul; 182(1):261-6. PubMed ID: 7540654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology.
    Aichele P; Brduscha-Riem K; Oehen S; Odermatt B; Zinkernagel RM; Hengartner H; Pircher H
    Immunity; 1997 May; 6(5):519-29. PubMed ID: 9175830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological tolerance to LCMV antigens differently affects control of acute and chronic virus infection in mice.
    Woopen C; Straub T; Schweier O; Aichele U; Düker K; Boehm T; Pircher H
    Eur J Immunol; 2018 Jan; 48(1):120-127. PubMed ID: 28921501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein.
    Hany M; Oehen S; Schulz M; Hengartner H; Mackett M; Bishop DH; Overton H; Zinkernagel RM
    Eur J Immunol; 1989 Mar; 19(3):417-24. PubMed ID: 2468501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role for activation of antigen-presenting cells in priming of cytotoxic T cell responses after vaccination with virus-like particles.
    Storni T; Lechner F; Erdmann I; Bächi T; Jegerlehner A; Dumrese T; Kündig TM; Ruedl C; Bachmann MF
    J Immunol; 2002 Mar; 168(6):2880-6. PubMed ID: 11884458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells efficiently induce protective antiviral immunity.
    Ludewig B; Ehl S; Karrer U; Odermatt B; Hengartner H; Zinkernagel RM
    J Virol; 1998 May; 72(5):3812-8. PubMed ID: 9557664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus.
    Whitton JL; Gebhard JR; Lewicki H; Tishon A; Oldstone MB
    J Virol; 1988 Mar; 62(3):687-95. PubMed ID: 2448497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo induction of a high-avidity, high-frequency cytotoxic T-lymphocyte response is associated with antiviral protective immunity.
    Sedlik C; Dadaglio G; Saron MF; Deriaud E; Rojas M; Casal SI; Leclerc C
    J Virol; 2000 Jul; 74(13):5769-75. PubMed ID: 10846055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of CTL responses to early viral antigens facilitates viral persistence.
    Schildknecht A; Welti S; Geuking MB; Hangartner L; van den Broek M
    J Immunol; 2008 Mar; 180(5):3113-21. PubMed ID: 18292534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
    von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
    J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model.
    Ehl S; Hombach J; Aichele P; Hengartner H; Zinkernagel RM
    J Exp Med; 1997 Apr; 185(7):1241-51. PubMed ID: 9104811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymic selection and adaptability of cytotoxic T lymphocyte responses in transgenic mice expressing a viral protein in the thymus.
    von Herrath MG; Dockter J; Nerenberg M; Gairin JE; Oldstone MB
    J Exp Med; 1994 Nov; 180(5):1901-10. PubMed ID: 7525843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Db- and Kb-restricted subdominant cytotoxic T-cell responses in lymphocytic choriomeningitis virus-infected mice.
    van der Most RG; Murali-Krishna K; Whitton JL; Oseroff C; Alexander J; Southwood S; Sidney J; Chesnut RW; Sette A; Ahmed R
    Virology; 1998 Jan; 240(1):158-67. PubMed ID: 9448700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited in vivo reactivity of polyclonal effector cytotoxic T cells towards altered peptide ligands.
    Bättig P; Saudan P; Storni T; Gallimore A; Bachmann MF
    Microbes Infect; 2005 Apr; 7(4):729-37. PubMed ID: 15857805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo.
    Prévost-Blondel A; Zimmermann C; Stemmer C; Kulmburg P; Rosenthal FM; Pircher H
    J Immunol; 1998 Sep; 161(5):2187-94. PubMed ID: 9725210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells.
    Gallimore A; Hombach J; Dumrese T; Rammensee HG; Zinkernagel RM; Hengartner H
    Eur J Immunol; 1998 Oct; 28(10):3301-11. PubMed ID: 9808199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides.
    Kyburz D; Aichele P; Speiser DE; Hengartner H; Zinkernagel RM; Pircher H
    Eur J Immunol; 1993 Aug; 23(8):1956-62. PubMed ID: 8344359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential immune recognition of LCMV nucleoprotein and glycoprotein in transgenic mice expressing LCMV cDNA genes.
    Zeller JC; Nguyen N; Southern PJ
    Virology; 1997 May; 231(2):290-300. PubMed ID: 9168891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The signal sequence of lymphocytic choriomeningitis virus contains an immunodominant cytotoxic T cell epitope that is restricted by both H-2D(b) and H-2K(b) molecules.
    Hudrisier D; Oldstone MB; Gairin JE
    Virology; 1997 Jul; 234(1):62-73. PubMed ID: 9234947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.